146 related articles for article (PubMed ID: 24803482)
1. Clinicopathological differences between interval and screen-detected breast cancers diagnosed within a screening programme in Northern Portugal.
José Bento M; Gonçalves G; Aguiar A; Antunes L; Veloso V; Rodrigues V
J Med Screen; 2014 Jun; 21(2):104-9. PubMed ID: 24803482
[TBL] [Abstract][Full Text] [Related]
2. Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.
Bento MJ; Gonçalves G; Aguiar A; Castro C; Veloso V; Rodrigues V
Cancer Epidemiol; 2015 Oct; 39(5):783-9. PubMed ID: 26315486
[TBL] [Abstract][Full Text] [Related]
3. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
5. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
6. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
7. Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme.
Hofvind S; Bjurstam N; Sørum R; Bjørndal H; Thoresen S; Skaane P
J Med Screen; 2006; 13(4):192-6. PubMed ID: 17217608
[TBL] [Abstract][Full Text] [Related]
8. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
[TBL] [Abstract][Full Text] [Related]
9. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
[TBL] [Abstract][Full Text] [Related]
10. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.
O'Brien KM; Mooney T; Fitzpatrick P; Sharp L
Breast Cancer Res Treat; 2018 Nov; 172(1):133-142. PubMed ID: 30006795
[TBL] [Abstract][Full Text] [Related]
11. Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study.
Timmermans L; De Brabander I; Van Damme N; Bleyen L; Martens P; Van Herck K; Thierens H; Bacher K; Depypere H
Maturitas; 2022 Apr; 158():55-60. PubMed ID: 35241239
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.
Henderson LM; Miglioretti DL; Kerlikowske K; Wernli KJ; Sprague BL; Lehman CD
AJR Am J Roentgenol; 2015 Sep; 205(3):676-84. PubMed ID: 26295657
[TBL] [Abstract][Full Text] [Related]
14. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
[TBL] [Abstract][Full Text] [Related]
15. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.
Musolino A; Michiara M; Conti GM; Boggiani D; Zatelli M; Palleschi D; Bella MA; Sgargi P; Di Blasio B; Ardizzoni A
J Clin Oncol; 2012 Jul; 30(19):2362-8. PubMed ID: 22585698
[TBL] [Abstract][Full Text] [Related]
17. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
18. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
19. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
[TBL] [Abstract][Full Text] [Related]
20. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]